Changes
On 28 June 2023 at 7:31:45 am UTC, ckan_admin:
-
No fields were updated. See the metadata diff for more details.
f | 1 | { | f | 1 | { |
2 | "author": "", | 2 | "author": "", | ||
3 | "author_email": "", | 3 | "author_email": "", | ||
4 | "creator_user_id": "ad823657-25d6-44fa-84f9-59872bdc984c", | 4 | "creator_user_id": "ad823657-25d6-44fa-84f9-59872bdc984c", | ||
5 | "extras": [ | 5 | "extras": [ | ||
6 | { | 6 | { | ||
7 | "key": "ADP ID", | 7 | "key": "ADP ID", | ||
8 | "value": | 8 | "value": | ||
9 | -TUA_PHIDU-UoM_AURIN_DB_1:phidu_estimates_chronic_disease_lga_2017_18" | 9 | -TUA_PHIDU-UoM_AURIN_DB_1:phidu_estimates_chronic_disease_lga_2017_18" | ||
10 | }, | 10 | }, | ||
11 | { | 11 | { | ||
12 | "key": "Access Level", | 12 | "key": "Access Level", | ||
13 | "value": "Open Access" | 13 | "value": "Open Access" | ||
14 | }, | 14 | }, | ||
15 | { | 15 | { | ||
16 | "key": "Aggregation Level", | 16 | "key": "Aggregation Level", | ||
17 | "value": "lga2016" | 17 | "value": "lga2016" | ||
18 | }, | 18 | }, | ||
19 | { | 19 | { | ||
20 | "key": "Attribute List", | 20 | "key": "Attribute List", | ||
21 | "value": ", Estimated Number Of Females With Mental And | 21 | "value": ", Estimated Number Of Females With Mental And | ||
22 | Behavioural Problems (Modelled Estimates) 2017-18 Asr Per 100, | 22 | Behavioural Problems (Modelled Estimates) 2017-18 Asr Per 100, | ||
23 | Estimated Number Of Females With Mental And Behavioural Problems | 23 | Estimated Number Of Females With Mental And Behavioural Problems | ||
24 | (Modelled Estimates) 2017-18 Asr Per 100 - Lower 95% C.I., Estimated | 24 | (Modelled Estimates) 2017-18 Asr Per 100 - Lower 95% C.I., Estimated | ||
25 | Number Of Females With Mental And Behavioural Problems (Modelled | 25 | Number Of Females With Mental And Behavioural Problems (Modelled | ||
26 | Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., Estimated Number Of | 26 | Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., Estimated Number Of | ||
27 | Females With Mental And Behavioural Problems (Modelled Estimates) | 27 | Females With Mental And Behavioural Problems (Modelled Estimates) | ||
28 | 2017-18 Number, Estimated Number Of Females With Mental And | 28 | 2017-18 Number, Estimated Number Of Females With Mental And | ||
29 | Behavioural Problems (Modelled Estimates) 2017-18 Rrmse, Estimated | 29 | Behavioural Problems (Modelled Estimates) 2017-18 Rrmse, Estimated | ||
30 | Number Of Females With Mental And Behavioural Problems (Modelled | 30 | Number Of Females With Mental And Behavioural Problems (Modelled | ||
31 | Estimates) 2017-18 Sr, Estimated Number Of Females With Mental And | 31 | Estimates) 2017-18 Sr, Estimated Number Of Females With Mental And | ||
32 | Behavioural Problems (Modelled Estimates) 2017-18 Sr - Lower 95% | 32 | Behavioural Problems (Modelled Estimates) 2017-18 Sr - Lower 95% | ||
33 | C.I., Estimated Number Of Females With Mental And Behavioural Problems | 33 | C.I., Estimated Number Of Females With Mental And Behavioural Problems | ||
34 | (Modelled Estimates) 2017-18 Sr - Upper 95% C.I., Estimated Number Of | 34 | (Modelled Estimates) 2017-18 Sr - Upper 95% C.I., Estimated Number Of | ||
35 | Males With Mental And Behavioural Problems (Modelled Estimates) | 35 | Males With Mental And Behavioural Problems (Modelled Estimates) | ||
36 | 2017-18 Asr Per 100, Estimated Number Of Males With Mental And | 36 | 2017-18 Asr Per 100, Estimated Number Of Males With Mental And | ||
37 | Behavioural Problems (Modelled Estimates) 2017-18 Asr Per 100 - Lower | 37 | Behavioural Problems (Modelled Estimates) 2017-18 Asr Per 100 - Lower | ||
38 | 95% C.I., Estimated Number Of Males With Mental And Behavioural | 38 | 95% C.I., Estimated Number Of Males With Mental And Behavioural | ||
39 | Problems (Modelled Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., | 39 | Problems (Modelled Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., | ||
40 | Estimated Number Of Males With Mental And Behavioural Problems | 40 | Estimated Number Of Males With Mental And Behavioural Problems | ||
41 | (Modelled Estimates) 2017-18 Number, Estimated Number Of Males With | 41 | (Modelled Estimates) 2017-18 Number, Estimated Number Of Males With | ||
42 | Mental And Behavioural Problems (Modelled Estimates) 2017-18 Rrmse, | 42 | Mental And Behavioural Problems (Modelled Estimates) 2017-18 Rrmse, | ||
43 | Estimated Number Of Males With Mental And Behavioural Problems | 43 | Estimated Number Of Males With Mental And Behavioural Problems | ||
44 | (Modelled Estimates) 2017-18 Sr, Estimated Number Of Males With Mental | 44 | (Modelled Estimates) 2017-18 Sr, Estimated Number Of Males With Mental | ||
45 | And Behavioural Problems (Modelled Estimates) 2017-18 Sr - Lower 95% | 45 | And Behavioural Problems (Modelled Estimates) 2017-18 Sr - Lower 95% | ||
46 | C.I., Estimated Number Of Males With Mental And Behavioural Problems | 46 | C.I., Estimated Number Of Males With Mental And Behavioural Problems | ||
47 | (Modelled Estimates) 2017-18 Sr - Upper 95% C.I., Estimated Number Of | 47 | (Modelled Estimates) 2017-18 Sr - Upper 95% C.I., Estimated Number Of | ||
48 | People With Arthritis (Modelled Estimates) 2017-18 Asr Per 100, | 48 | People With Arthritis (Modelled Estimates) 2017-18 Asr Per 100, | ||
49 | Estimated Number Of People With Arthritis (Modelled Estimates) | 49 | Estimated Number Of People With Arthritis (Modelled Estimates) | ||
50 | 2017-18 Asr Per 100 - Lower 95% C.I., Estimated Number Of People With | 50 | 2017-18 Asr Per 100 - Lower 95% C.I., Estimated Number Of People With | ||
51 | Arthritis (Modelled Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., | 51 | Arthritis (Modelled Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., | ||
52 | Estimated Number Of People With Arthritis (Modelled Estimates) | 52 | Estimated Number Of People With Arthritis (Modelled Estimates) | ||
53 | 2017-18 Number, Estimated Number Of People With Arthritis (Modelled | 53 | 2017-18 Number, Estimated Number Of People With Arthritis (Modelled | ||
54 | Estimates) 2017-18 Rrmse, Estimated Number Of People With Arthritis | 54 | Estimates) 2017-18 Rrmse, Estimated Number Of People With Arthritis | ||
55 | (Modelled Estimates) 2017-18 Sr, Estimated Number Of People With | 55 | (Modelled Estimates) 2017-18 Sr, Estimated Number Of People With | ||
56 | Arthritis (Modelled Estimates) 2017-18 Sr - Lower 95% C.I., Estimated | 56 | Arthritis (Modelled Estimates) 2017-18 Sr - Lower 95% C.I., Estimated | ||
57 | Number Of People With Arthritis (Modelled Estimates) 2017-18 Sr - | 57 | Number Of People With Arthritis (Modelled Estimates) 2017-18 Sr - | ||
58 | Upper 95% C.I., Estimated Number Of People With Asthma (Modelled | 58 | Upper 95% C.I., Estimated Number Of People With Asthma (Modelled | ||
59 | Estimates) 2017-18 Asr Per 100, Estimated Number Of People With Asthma | 59 | Estimates) 2017-18 Asr Per 100, Estimated Number Of People With Asthma | ||
60 | (Modelled Estimates) 2017-18 Asr Per 100 - Lower 95% C.I., Estimated | 60 | (Modelled Estimates) 2017-18 Asr Per 100 - Lower 95% C.I., Estimated | ||
61 | Number Of People With Asthma (Modelled Estimates) 2017-18 Asr Per 100 | 61 | Number Of People With Asthma (Modelled Estimates) 2017-18 Asr Per 100 | ||
62 | - Upper 95% C.I., Estimated Number Of People With Asthma (Modelled | 62 | - Upper 95% C.I., Estimated Number Of People With Asthma (Modelled | ||
63 | Estimates) 2017-18 Number, Estimated Number Of People With Asthma | 63 | Estimates) 2017-18 Number, Estimated Number Of People With Asthma | ||
64 | (Modelled Estimates) 2017-18 Rrmse, Estimated Number Of People With | 64 | (Modelled Estimates) 2017-18 Rrmse, Estimated Number Of People With | ||
65 | Asthma (Modelled Estimates) 2017-18 Sr, Estimated Number Of People | 65 | Asthma (Modelled Estimates) 2017-18 Sr, Estimated Number Of People | ||
66 | With Asthma (Modelled Estimates) 2017-18 Sr - Lower 95% C.I., | 66 | With Asthma (Modelled Estimates) 2017-18 Sr - Lower 95% C.I., | ||
67 | Estimated Number Of People With Asthma (Modelled Estimates) 2017-18 | 67 | Estimated Number Of People With Asthma (Modelled Estimates) 2017-18 | ||
68 | Sr - Upper 95% C.I., Estimated Number Of People With Chronic | 68 | Sr - Upper 95% C.I., Estimated Number Of People With Chronic | ||
69 | Obstructive Pulmonary Disease (Modelled Estimates) 2017-18 Asr Per | 69 | Obstructive Pulmonary Disease (Modelled Estimates) 2017-18 Asr Per | ||
70 | 100, Estimated Number Of People With Chronic Obstructive Pulmonary | 70 | 100, Estimated Number Of People With Chronic Obstructive Pulmonary | ||
71 | Disease (Modelled Estimates) 2017-18 Asr Per 100 - Lower 95% C.I., | 71 | Disease (Modelled Estimates) 2017-18 Asr Per 100 - Lower 95% C.I., | ||
72 | Estimated Number Of People With Chronic Obstructive Pulmonary Disease | 72 | Estimated Number Of People With Chronic Obstructive Pulmonary Disease | ||
73 | (Modelled Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., Estimated | 73 | (Modelled Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., Estimated | ||
74 | Number Of People With Chronic Obstructive Pulmonary Disease (Modelled | 74 | Number Of People With Chronic Obstructive Pulmonary Disease (Modelled | ||
75 | Estimates) 2017-18 Number, Estimated Number Of People With Chronic | 75 | Estimates) 2017-18 Number, Estimated Number Of People With Chronic | ||
76 | Obstructive Pulmonary Disease (Modelled Estimates) 2017-18 Rrmse, | 76 | Obstructive Pulmonary Disease (Modelled Estimates) 2017-18 Rrmse, | ||
77 | Estimated Number Of People With Chronic Obstructive Pulmonary Disease | 77 | Estimated Number Of People With Chronic Obstructive Pulmonary Disease | ||
78 | (Modelled Estimates) 2017-18 Sr, Estimated Number Of People With | 78 | (Modelled Estimates) 2017-18 Sr, Estimated Number Of People With | ||
79 | Chronic Obstructive Pulmonary Disease (Modelled Estimates) 2017-18 Sr | 79 | Chronic Obstructive Pulmonary Disease (Modelled Estimates) 2017-18 Sr | ||
80 | - Lower 95% C.I., Estimated Number Of People With Chronic Obstructive | 80 | - Lower 95% C.I., Estimated Number Of People With Chronic Obstructive | ||
81 | Pulmonary Disease (Modelled Estimates) 2017-18 Sr - Upper 95% C.I., | 81 | Pulmonary Disease (Modelled Estimates) 2017-18 Sr - Upper 95% C.I., | ||
82 | Estimated Number Of People With Diabetes Mellitus (Modelled | 82 | Estimated Number Of People With Diabetes Mellitus (Modelled | ||
83 | Estimates) 2017-18 Asr Per 100, Estimated Number Of People With | 83 | Estimates) 2017-18 Asr Per 100, Estimated Number Of People With | ||
84 | Diabetes Mellitus (Modelled Estimates) 2017-18 Asr Per 100 - Lower | 84 | Diabetes Mellitus (Modelled Estimates) 2017-18 Asr Per 100 - Lower | ||
85 | 95% C.I., Estimated Number Of People With Diabetes Mellitus (Modelled | 85 | 95% C.I., Estimated Number Of People With Diabetes Mellitus (Modelled | ||
86 | Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., Estimated Number Of | 86 | Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., Estimated Number Of | ||
87 | People With Diabetes Mellitus (Modelled Estimates) 2017-18 Number, | 87 | People With Diabetes Mellitus (Modelled Estimates) 2017-18 Number, | ||
88 | Estimated Number Of People With Diabetes Mellitus (Modelled | 88 | Estimated Number Of People With Diabetes Mellitus (Modelled | ||
89 | Estimates) 2017-18 Rrmse, Estimated Number Of People With Diabetes | 89 | Estimates) 2017-18 Rrmse, Estimated Number Of People With Diabetes | ||
90 | Mellitus (Modelled Estimates) 2017-18 Sr, Estimated Number Of People | 90 | Mellitus (Modelled Estimates) 2017-18 Sr, Estimated Number Of People | ||
91 | With Diabetes Mellitus (Modelled Estimates) 2017-18 Sr - Lower 95% | 91 | With Diabetes Mellitus (Modelled Estimates) 2017-18 Sr - Lower 95% | ||
92 | C.I., Estimated Number Of People With Diabetes Mellitus (Modelled | 92 | C.I., Estimated Number Of People With Diabetes Mellitus (Modelled | ||
93 | Estimates) 2017-18 Sr - Upper 95% C.I., Estimated Number Of People | 93 | Estimates) 2017-18 Sr - Upper 95% C.I., Estimated Number Of People | ||
94 | With Heart, Stroke And Vascular Disease (Modelled Estimates) 2017-18 | 94 | With Heart, Stroke And Vascular Disease (Modelled Estimates) 2017-18 | ||
95 | Asr Per 100, Estimated Number Of People With Heart, Stroke And | 95 | Asr Per 100, Estimated Number Of People With Heart, Stroke And | ||
96 | Vascular Disease (Modelled Estimates) 2017-18 Asr Per 100 - Lower 95% | 96 | Vascular Disease (Modelled Estimates) 2017-18 Asr Per 100 - Lower 95% | ||
97 | C.I., Estimated Number Of People With Heart, Stroke And Vascular | 97 | C.I., Estimated Number Of People With Heart, Stroke And Vascular | ||
98 | Disease (Modelled Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., | 98 | Disease (Modelled Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., | ||
99 | Estimated Number Of People With Heart, Stroke And Vascular Disease | 99 | Estimated Number Of People With Heart, Stroke And Vascular Disease | ||
100 | (Modelled Estimates) 2017-18 Number, Estimated Number Of People With | 100 | (Modelled Estimates) 2017-18 Number, Estimated Number Of People With | ||
101 | Heart, Stroke And Vascular Disease (Modelled Estimates) 2017-18 | 101 | Heart, Stroke And Vascular Disease (Modelled Estimates) 2017-18 | ||
102 | Rrmse, Estimated Number Of People With Heart, Stroke And Vascular | 102 | Rrmse, Estimated Number Of People With Heart, Stroke And Vascular | ||
103 | Disease (Modelled Estimates) 2017-18 Sr, Estimated Number Of People | 103 | Disease (Modelled Estimates) 2017-18 Sr, Estimated Number Of People | ||
104 | With Heart, Stroke And Vascular Disease (Modelled Estimates) 2017-18 | 104 | With Heart, Stroke And Vascular Disease (Modelled Estimates) 2017-18 | ||
105 | Sr - Lower 95% C.I., Estimated Number Of People With Heart, Stroke And | 105 | Sr - Lower 95% C.I., Estimated Number Of People With Heart, Stroke And | ||
106 | Vascular Disease (Modelled Estimates) 2017-18 Sr - Upper 95% C.I., | 106 | Vascular Disease (Modelled Estimates) 2017-18 Sr - Upper 95% C.I., | ||
107 | Estimated Number Of People With Mental And Behavioural Problems | 107 | Estimated Number Of People With Mental And Behavioural Problems | ||
108 | (Modelled Estimates) 2017-18 Asr Per 100, Estimated Number Of People | 108 | (Modelled Estimates) 2017-18 Asr Per 100, Estimated Number Of People | ||
109 | With Mental And Behavioural Problems (Modelled Estimates) 2017-18 Asr | 109 | With Mental And Behavioural Problems (Modelled Estimates) 2017-18 Asr | ||
110 | Per 100 - Lower 95% C.I., Estimated Number Of People With Mental And | 110 | Per 100 - Lower 95% C.I., Estimated Number Of People With Mental And | ||
111 | Behavioural Problems (Modelled Estimates) 2017-18 Asr Per 100 - Upper | 111 | Behavioural Problems (Modelled Estimates) 2017-18 Asr Per 100 - Upper | ||
112 | 95% C.I., Estimated Number Of People With Mental And Behavioural | 112 | 95% C.I., Estimated Number Of People With Mental And Behavioural | ||
113 | Problems (Modelled Estimates) 2017-18 Number, Estimated Number Of | 113 | Problems (Modelled Estimates) 2017-18 Number, Estimated Number Of | ||
114 | People With Mental And Behavioural Problems (Modelled Estimates) | 114 | People With Mental And Behavioural Problems (Modelled Estimates) | ||
115 | 2017-18 Rrmse, Estimated Number Of People With Mental And Behavioural | 115 | 2017-18 Rrmse, Estimated Number Of People With Mental And Behavioural | ||
116 | Problems (Modelled Estimates) 2017-18 Sr, Estimated Number Of People | 116 | Problems (Modelled Estimates) 2017-18 Sr, Estimated Number Of People | ||
117 | With Mental And Behavioural Problems (Modelled Estimates) 2017-18 Sr | 117 | With Mental And Behavioural Problems (Modelled Estimates) 2017-18 Sr | ||
118 | - Lower 95% C.I., Estimated Number Of People With Mental And | 118 | - Lower 95% C.I., Estimated Number Of People With Mental And | ||
119 | Behavioural Problems (Modelled Estimates) 2017-18 Sr - Upper 95% | 119 | Behavioural Problems (Modelled Estimates) 2017-18 Sr - Upper 95% | ||
120 | C.I., Estimated Number Of People With Osteoporosis (Modelled | 120 | C.I., Estimated Number Of People With Osteoporosis (Modelled | ||
121 | Estimates) 2017-18 Asr Per 100, Estimated Number Of People With | 121 | Estimates) 2017-18 Asr Per 100, Estimated Number Of People With | ||
122 | Osteoporosis (Modelled Estimates) 2017-18 Asr Per 100 - Lower 95% | 122 | Osteoporosis (Modelled Estimates) 2017-18 Asr Per 100 - Lower 95% | ||
123 | C.I., Estimated Number Of People With Osteoporosis (Modelled | 123 | C.I., Estimated Number Of People With Osteoporosis (Modelled | ||
124 | Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., Estimated Number Of | 124 | Estimates) 2017-18 Asr Per 100 - Upper 95% C.I., Estimated Number Of | ||
125 | People With Osteoporosis (Modelled Estimates) 2017-18 Number, | 125 | People With Osteoporosis (Modelled Estimates) 2017-18 Number, | ||
126 | Estimated Number Of People With Osteoporosis (Modelled Estimates) | 126 | Estimated Number Of People With Osteoporosis (Modelled Estimates) | ||
127 | 2017-18 Rrmse, Estimated Number Of People With Osteoporosis (Modelled | 127 | 2017-18 Rrmse, Estimated Number Of People With Osteoporosis (Modelled | ||
128 | Estimates) 2017-18 Sr, Estimated Number Of People With Osteoporosis | 128 | Estimates) 2017-18 Sr, Estimated Number Of People With Osteoporosis | ||
129 | (Modelled Estimates) 2017-18 Sr - Lower 95% C.I., Estimated Number Of | 129 | (Modelled Estimates) 2017-18 Sr - Lower 95% C.I., Estimated Number Of | ||
130 | People With Osteoporosis (Modelled Estimates) 2017-18 Sr - Upper 95% | 130 | People With Osteoporosis (Modelled Estimates) 2017-18 Sr - Upper 95% | ||
131 | C.I., LGA Code 2016, LGA Name 2016, Link To Notes On The Data Link To | 131 | C.I., LGA Code 2016, LGA Name 2016, Link To Notes On The Data Link To | ||
132 | Australian And State/ Territory Totals Quality Indicator*" | 132 | Australian And State/ Territory Totals Quality Indicator*" | ||
133 | }, | 133 | }, | ||
134 | { | 134 | { | ||
135 | "key": "Attribution", | 135 | "key": "Attribution", | ||
136 | "value": "Torrens University Australia - Public Health | 136 | "value": "Torrens University Australia - Public Health | ||
137 | Information Development Unit, (2021): PHIDU - Prevalence of Chronic | 137 | Information Development Unit, (2021): PHIDU - Prevalence of Chronic | ||
138 | Diseases (LGA) 2017-2018; accessed from AURIN on [date of access]." | 138 | Diseases (LGA) 2017-2018; accessed from AURIN on [date of access]." | ||
139 | }, | 139 | }, | ||
140 | { | 140 | { | ||
141 | "key": "Coordinate Ref. System", | 141 | "key": "Coordinate Ref. System", | ||
142 | "value": "EPSG:4283 (GDA_1994)" | 142 | "value": "EPSG:4283 (GDA_1994)" | ||
143 | }, | 143 | }, | ||
144 | { | 144 | { | ||
145 | "key": "Copyright Notice", | 145 | "key": "Copyright Notice", | ||
146 | "value": "\u00a9 Torrens University Australia - Public Health | 146 | "value": "\u00a9 Torrens University Australia - Public Health | ||
147 | Information Development Unit 2021" | 147 | Information Development Unit 2021" | ||
148 | }, | 148 | }, | ||
149 | { | 149 | { | ||
150 | "key": "Geometry Field", | 150 | "key": "Geometry Field", | ||
151 | "value": "geom" | 151 | "value": "geom" | ||
152 | }, | 152 | }, | ||
153 | { | 153 | { | ||
154 | "key": "Key", | 154 | "key": "Key", | ||
155 | "value": "lga_code" | 155 | "value": "lga_code" | ||
156 | }, | 156 | }, | ||
157 | { | 157 | { | ||
158 | "key": "Type", | 158 | "key": "Type", | ||
159 | "value": "dataset" | 159 | "value": "dataset" | ||
160 | }, | 160 | }, | ||
161 | { | 161 | { | ||
162 | "key": "spatial", | 162 | "key": "spatial", | ||
163 | "value": "{\"type\": \"Polygon\", \"coordinates\": [[[96.81, | 163 | "value": "{\"type\": \"Polygon\", \"coordinates\": [[[96.81, | ||
164 | -43.75], [159.11, -43.75], [159.11, -9.14], [96.81, -9.14], [96.81, | 164 | -43.75], [159.11, -43.75], [159.11, -9.14], [96.81, -9.14], [96.81, | ||
165 | -43.75]]]}" | 165 | -43.75]]]}" | ||
166 | } | 166 | } | ||
167 | ], | 167 | ], | ||
n | 168 | "groups": [], | n | 168 | "groups": [ |
169 | { | ||||
170 | "description": "Data licenced under various Open Data licences. | ||||
171 | Please check the licence for each dataset individually. To gain access | ||||
172 | head to the [ADP Access Dashboard](https://adp-access.aurin.org.au/) | ||||
173 | and accept the ADP Terms of Use.", | ||||
174 | "display_name": "Open Access", | ||||
175 | "id": "dbc8a185-ce67-449c-850e-afa744887450", | ||||
176 | "image_display_url": | ||||
177 | "https://resources.aurin.org.au/icons/unlocked_orange.png", | ||||
178 | "name": "open", | ||||
179 | "title": "Open Access" | ||||
180 | } | ||||
181 | ], | ||||
169 | "id": "60a70d9f-6b66-4128-bf49-88ef175de96d", | 182 | "id": "60a70d9f-6b66-4128-bf49-88ef175de96d", | ||
170 | "isopen": true, | 183 | "isopen": true, | ||
171 | "license_id": "CC-BY-NC-SA-3.0-AU", | 184 | "license_id": "CC-BY-NC-SA-3.0-AU", | ||
172 | "license_title": "Creative Commons | 185 | "license_title": "Creative Commons | ||
173 | Attribution-NonCommercial-ShareAlike 3.0 Australia (CC BY-NC-SA 3.0 | 186 | Attribution-NonCommercial-ShareAlike 3.0 Australia (CC BY-NC-SA 3.0 | ||
174 | AU)", | 187 | AU)", | ||
175 | "license_url": | 188 | "license_url": | ||
176 | "https://creativecommons.org/licenses/by-nc-sa/3.0/au/", | 189 | "https://creativecommons.org/licenses/by-nc-sa/3.0/au/", | ||
177 | "maintainer": null, | 190 | "maintainer": null, | ||
178 | "maintainer_email": null, | 191 | "maintainer_email": null, | ||
179 | "metadata_created": "2023-06-28T07:31:44.703023", | 192 | "metadata_created": "2023-06-28T07:31:44.703023", | ||
t | 180 | "metadata_modified": "2023-06-28T07:31:44.969074", | t | 193 | "metadata_modified": "2023-06-28T07:31:45.226391", |
181 | "name": | 194 | "name": | ||
182 | "tua-phidu-phidu-estimates-chronic-disease-lga-2017-18-lga2016", | 195 | "tua-phidu-phidu-estimates-chronic-disease-lga-2017-18-lga2016", | ||
183 | "notes": "This dataset, released January 2020, contains for the time | 196 | "notes": "This dataset, released January 2020, contains for the time | ||
184 | period of 2017-2018 the Estimated population, aged 18 years and over | 197 | period of 2017-2018 the Estimated population, aged 18 years and over | ||
185 | with diabetes mellitus; Estimated male population with mental and | 198 | with diabetes mellitus; Estimated male population with mental and | ||
186 | behavioural problems; Estimated female population with mental and | 199 | behavioural problems; Estimated female population with mental and | ||
187 | behavioural problems; Estimated population with mental and behavioural | 200 | behavioural problems; Estimated population with mental and behavioural | ||
188 | problems; Estimated population with heart, stroke and vascular | 201 | problems; Estimated population with heart, stroke and vascular | ||
189 | disease; Estimated population with asthma; Estimated population with | 202 | disease; Estimated population with asthma; Estimated population with | ||
190 | chronic obstructive pulmonary disease; Estimated population with | 203 | chronic obstructive pulmonary disease; Estimated population with | ||
191 | arthritis; Estimated population with osteoporosis; The data is by | 204 | arthritis; Estimated population with osteoporosis; The data is by | ||
192 | Local Government Area (LGA) 2016 geographic boundaries.\n\nFor more | 205 | Local Government Area (LGA) 2016 geographic boundaries.\n\nFor more | ||
193 | information please see the [data source | 206 | information please see the [data source | ||
194 | rrens.edu.au/current/data/sha-aust/notes/phidu_data_sources_notes.pdf) | 207 | rrens.edu.au/current/data/sha-aust/notes/phidu_data_sources_notes.pdf) | ||
195 | on the data. \n\nSource: Estimates for Population Health Areas (PHAs) | 208 | on the data. \n\nSource: Estimates for Population Health Areas (PHAs) | ||
196 | are modelled estimates and were produced by the ABS; estimates at the | 209 | are modelled estimates and were produced by the ABS; estimates at the | ||
197 | LGA and PHN level were derived from the PHA estimates.\n\n AURIN has | 210 | LGA and PHN level were derived from the PHA estimates.\n\n AURIN has | ||
198 | spatially enabled the [original | 211 | spatially enabled the [original | ||
199 | lases/data#social-health-atlases-of-australia-local-government-areas). | 212 | lases/data#social-health-atlases-of-australia-local-government-areas). | ||
200 | Data that was not shown/not applicable/not published/not available for | 213 | Data that was not shown/not applicable/not published/not available for | ||
201 | the specific area ('#', '..', '^', 'np, 'n.a.', 'n.y.a.' in original | 214 | the specific area ('#', '..', '^', 'np, 'n.a.', 'n.y.a.' in original | ||
202 | PHIDU data) was removed.It has been replaced by by Blank cells. For | 215 | PHIDU data) was removed.It has been replaced by by Blank cells. For | ||
203 | other keys and abbreviations refer to [PHIDU | 216 | other keys and abbreviations refer to [PHIDU | ||
204 | Keys](https://cloudstor.aarnet.edu.au/plus/s/1ryaKpnBQB6cMCp).", | 217 | Keys](https://cloudstor.aarnet.edu.au/plus/s/1ryaKpnBQB6cMCp).", | ||
205 | "num_resources": 1, | 218 | "num_resources": 1, | ||
206 | "num_tags": 2, | 219 | "num_tags": 2, | ||
207 | "organization": { | 220 | "organization": { | ||
208 | "approval_status": "approved", | 221 | "approval_status": "approved", | ||
209 | "created": "2023-06-28T06:14:34.290612", | 222 | "created": "2023-06-28T06:14:34.290612", | ||
210 | "description": "", | 223 | "description": "", | ||
211 | "id": "6af2fd4d-8220-4ab1-9b53-b5932f04915b", | 224 | "id": "6af2fd4d-8220-4ab1-9b53-b5932f04915b", | ||
212 | "image_url": | 225 | "image_url": | ||
213 | "https://resources.aurin.org.au/ckan/logos/tua_phidu.png", | 226 | "https://resources.aurin.org.au/ckan/logos/tua_phidu.png", | ||
214 | "is_organization": true, | 227 | "is_organization": true, | ||
215 | "name": "tua_phidu", | 228 | "name": "tua_phidu", | ||
216 | "state": "active", | 229 | "state": "active", | ||
217 | "title": "Torrens University Australia - Public Health Information | 230 | "title": "Torrens University Australia - Public Health Information | ||
218 | Development Unit", | 231 | Development Unit", | ||
219 | "type": "organization" | 232 | "type": "organization" | ||
220 | }, | 233 | }, | ||
221 | "owner_org": "6af2fd4d-8220-4ab1-9b53-b5932f04915b", | 234 | "owner_org": "6af2fd4d-8220-4ab1-9b53-b5932f04915b", | ||
222 | "private": false, | 235 | "private": false, | ||
223 | "relationships_as_object": [], | 236 | "relationships_as_object": [], | ||
224 | "relationships_as_subject": [], | 237 | "relationships_as_subject": [], | ||
225 | "resources": [ | 238 | "resources": [ | ||
226 | { | 239 | { | ||
227 | "cache_last_updated": null, | 240 | "cache_last_updated": null, | ||
228 | "cache_url": null, | 241 | "cache_url": null, | ||
229 | "created": "2023-06-28T07:31:44.982861", | 242 | "created": "2023-06-28T07:31:44.982861", | ||
230 | "description": "Download this dataset via the AURIN Download | 243 | "description": "Download this dataset via the AURIN Download | ||
231 | Manager", | 244 | Manager", | ||
232 | "format": "HTML", | 245 | "format": "HTML", | ||
233 | "hash": "", | 246 | "hash": "", | ||
234 | "id": "7ec9421e-1746-4e53-8fa1-87f3b2134f61", | 247 | "id": "7ec9421e-1746-4e53-8fa1-87f3b2134f61", | ||
235 | "last_modified": null, | 248 | "last_modified": null, | ||
236 | "metadata_modified": "2023-06-28T07:31:44.975401", | 249 | "metadata_modified": "2023-06-28T07:31:44.975401", | ||
237 | "mimetype": null, | 250 | "mimetype": null, | ||
238 | "mimetype_inner": null, | 251 | "mimetype_inner": null, | ||
239 | "name": "AURIN Download Manager", | 252 | "name": "AURIN Download Manager", | ||
240 | "package_id": "60a70d9f-6b66-4128-bf49-88ef175de96d", | 253 | "package_id": "60a70d9f-6b66-4128-bf49-88ef175de96d", | ||
241 | "position": 0, | 254 | "position": 0, | ||
242 | "resource_type": null, | 255 | "resource_type": null, | ||
243 | "size": null, | 256 | "size": null, | ||
244 | "state": "active", | 257 | "state": "active", | ||
245 | "url": | 258 | "url": | ||
246 | ataset/tua-phidu-phidu-estimates-chronic-disease-lga-2017-18-lga2016", | 259 | ataset/tua-phidu-phidu-estimates-chronic-disease-lga-2017-18-lga2016", | ||
247 | "url_type": null | 260 | "url_type": null | ||
248 | } | 261 | } | ||
249 | ], | 262 | ], | ||
250 | "state": "active", | 263 | "state": "active", | ||
251 | "tags": [ | 264 | "tags": [ | ||
252 | { | 265 | { | ||
253 | "display_name": "HEALTH SCIENCES", | 266 | "display_name": "HEALTH SCIENCES", | ||
254 | "id": "eb3abd88-b95a-475a-9e1f-4a61d7b625fe", | 267 | "id": "eb3abd88-b95a-475a-9e1f-4a61d7b625fe", | ||
255 | "name": "HEALTH SCIENCES", | 268 | "name": "HEALTH SCIENCES", | ||
256 | "state": "active", | 269 | "state": "active", | ||
257 | "vocabulary_id": null | 270 | "vocabulary_id": null | ||
258 | }, | 271 | }, | ||
259 | { | 272 | { | ||
260 | "display_name": "Public health", | 273 | "display_name": "Public health", | ||
261 | "id": "d3679db4-8fcf-43f0-915d-823ee65d4e55", | 274 | "id": "d3679db4-8fcf-43f0-915d-823ee65d4e55", | ||
262 | "name": "Public health", | 275 | "name": "Public health", | ||
263 | "state": "active", | 276 | "state": "active", | ||
264 | "vocabulary_id": null | 277 | "vocabulary_id": null | ||
265 | } | 278 | } | ||
266 | ], | 279 | ], | ||
267 | "title": "PHIDU - Prevalence of Chronic Diseases (LGA) 2017-2018", | 280 | "title": "PHIDU - Prevalence of Chronic Diseases (LGA) 2017-2018", | ||
268 | "type": "dataset", | 281 | "type": "dataset", | ||
269 | "url": "https://adp.aurin.org.au/geoserver/wfs", | 282 | "url": "https://adp.aurin.org.au/geoserver/wfs", | ||
270 | "version": null | 283 | "version": null | ||
271 | } | 284 | } |